| 1. | | Recruiting | Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis
Conditions: Myocarditis; Giant Cell Myocarditis |
| 2. | | Completed | Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating |
| 3. | | No longer recruiting | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
Condition: Multiple Sclerosis |
| 4. | | No longer recruiting | Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone
Conditions: Acute Disseminated Encephalomyelitis; Devic's Syndrome; Marburg's variant of multiple sclerosis; Balo's Concentric Sclerosis; ... |
| 5. | | No longer recruiting | Pilot Study of Budesonide for Patients with Primary Sclerosing Cholangitis
Conditions: Cholangitis, Sclerosing; Liver Cirrhosis, Biliary |
| 6. | | No longer recruiting | Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients with Subacute Proximal Diabetic Neuropathy
Condition: Diabetic Neuropathies |
